# MITOCHEM THERAPEUTICS INC.: Novel gene mutation agnostic small molecule to treat retinitis pigmentosa

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | MITOCHEM THERAPEUTICS INC. |
| Location | CHARLESTON, SC |
| Project | Novel gene mutation agnostic small molecule to treat retinitis pigmentosa |
| Project number | 1R43EY037591-01A1 |
| Mechanism | R43 |
| Institute | National Eye Institute |
| Award | $320,790 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-30 to 2027-08-31 |
| UEI | D93QYNUYWXN5 |

## Why this score
- Award of $320,790.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11401308). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.